Skip to main content

TCG Crossover Management, LLC

SEC CIK
0001839948
Latest filing
Aug 14, 2026

MNPR holding history

Monopar Therapeutics in every 13F filed by TCG Crossover Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MNPR overviewAll 13F holders of MNPRFull Q2 2026 holdings

Shares (Q2 2026)
203,327
Value
$18.8M
% of portfolio
0.5%
Quarters held
4
Since Q3 2025
Holdings of MNPR by TCG Crossover Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026203,327$18.8M0.5%+71,224+53.9%AddedHolders
Q1 2026132,103$7.24M0.2%−9,812−6.9%ReducedHolders
Q4 2025141,915$9.27M0.3%−11,085−7.2%ReducedHolders
Q3 2025153,000$12.5M0.6%+153,000NewHolders